Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases

Three common Apolipoprotein E isoforms, ApoE2, ApoE3, and ApoE4, are key regulators of lipid homeostasis, among other functions. Apolipoprotein E can interact with amyloid proteins. The isoforms differ by one or two residues at positions 112 and 158, and possess distinct structural conformations and...

Full description

Bibliographic Details
Main Authors: Rolf Antonie Loch, Hongzhi Wang, Alex Perálvarez-Marín, Philipp Berger, Henrietta Nielsen, Angeliki Chroni, Jinghui Luo
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037023000223
_version_ 1827577693650026496
author Rolf Antonie Loch
Hongzhi Wang
Alex Perálvarez-Marín
Philipp Berger
Henrietta Nielsen
Angeliki Chroni
Jinghui Luo
author_facet Rolf Antonie Loch
Hongzhi Wang
Alex Perálvarez-Marín
Philipp Berger
Henrietta Nielsen
Angeliki Chroni
Jinghui Luo
author_sort Rolf Antonie Loch
collection DOAJ
description Three common Apolipoprotein E isoforms, ApoE2, ApoE3, and ApoE4, are key regulators of lipid homeostasis, among other functions. Apolipoprotein E can interact with amyloid proteins. The isoforms differ by one or two residues at positions 112 and 158, and possess distinct structural conformations and functions, leading to isoform-specific roles in amyloid-based neurodegenerative diseases. Over 30 different amyloid proteins have been found to share similar characteristics of structure and toxicity, suggesting a common interactome. The molecular and genetic interactions of ApoE with amyloid proteins have been extensively studied in neurodegenerative diseases, but have not yet been well connected and clarified. Here we summarize essential features of the interactions between ApoE and different amyloid proteins, identify gaps in the understanding of the interactome and propose the general interaction mechanism between ApoE isoforms and amyloid proteins. Perhaps more importantly, this review outlines what we can learn from the interactome of ApoE and amyloid proteins; that is the need to see both ApoE and amyloid proteins as a basis to understand neurodegenerative diseases.
first_indexed 2024-03-08T21:31:32Z
format Article
id doaj.art-b5df8e5a0b18462d977ed1bb7964472b
institution Directory Open Access Journal
issn 2001-0370
language English
last_indexed 2024-03-08T21:31:32Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Computational and Structural Biotechnology Journal
spelling doaj.art-b5df8e5a0b18462d977ed1bb7964472b2023-12-21T07:30:48ZengElsevierComputational and Structural Biotechnology Journal2001-03702023-01-012111891204Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseasesRolf Antonie Loch0Hongzhi Wang1Alex Perálvarez-Marín2Philipp Berger3Henrietta Nielsen4Angeliki Chroni5Jinghui Luo6Department of Biology and Chemistry, Paul Scherrer Institute, 5232 Villigen, SwitzerlandDepartment of Biology and Chemistry, Paul Scherrer Institute, 5232 Villigen, SwitzerlandBiophysics Unit, Department of Biochemistry and Molecular Biology, School of Medicine, Institut de Neurociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallés, Catalonia, SpainDepartment of Biology and Chemistry, Paul Scherrer Institute, 5232 Villigen, SwitzerlandDepartment of Biochemistry and Biophysics, Stockholm University, Svante Arrhenius Väg 16B, 10691 Stockholm, SwedenInstitute of Biosciences and Applications, National Center for Scientific Research 'Demokritos', 15341 Athens, GreeceDepartment of Biology and Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland; Corresponding author.Three common Apolipoprotein E isoforms, ApoE2, ApoE3, and ApoE4, are key regulators of lipid homeostasis, among other functions. Apolipoprotein E can interact with amyloid proteins. The isoforms differ by one or two residues at positions 112 and 158, and possess distinct structural conformations and functions, leading to isoform-specific roles in amyloid-based neurodegenerative diseases. Over 30 different amyloid proteins have been found to share similar characteristics of structure and toxicity, suggesting a common interactome. The molecular and genetic interactions of ApoE with amyloid proteins have been extensively studied in neurodegenerative diseases, but have not yet been well connected and clarified. Here we summarize essential features of the interactions between ApoE and different amyloid proteins, identify gaps in the understanding of the interactome and propose the general interaction mechanism between ApoE isoforms and amyloid proteins. Perhaps more importantly, this review outlines what we can learn from the interactome of ApoE and amyloid proteins; that is the need to see both ApoE and amyloid proteins as a basis to understand neurodegenerative diseases.http://www.sciencedirect.com/science/article/pii/S2001037023000223ApoEAmyloid proteinsInteractionEndogenous moleculesCytotoxicityTherapeutics
spellingShingle Rolf Antonie Loch
Hongzhi Wang
Alex Perálvarez-Marín
Philipp Berger
Henrietta Nielsen
Angeliki Chroni
Jinghui Luo
Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases
Computational and Structural Biotechnology Journal
ApoE
Amyloid proteins
Interaction
Endogenous molecules
Cytotoxicity
Therapeutics
title Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases
title_full Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases
title_fullStr Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases
title_full_unstemmed Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases
title_short Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases
title_sort cross interactions between apolipoprotein e and amyloid proteins in neurodegenerative diseases
topic ApoE
Amyloid proteins
Interaction
Endogenous molecules
Cytotoxicity
Therapeutics
url http://www.sciencedirect.com/science/article/pii/S2001037023000223
work_keys_str_mv AT rolfantonieloch crossinteractionsbetweenapolipoproteineandamyloidproteinsinneurodegenerativediseases
AT hongzhiwang crossinteractionsbetweenapolipoproteineandamyloidproteinsinneurodegenerativediseases
AT alexperalvarezmarin crossinteractionsbetweenapolipoproteineandamyloidproteinsinneurodegenerativediseases
AT philippberger crossinteractionsbetweenapolipoproteineandamyloidproteinsinneurodegenerativediseases
AT henriettanielsen crossinteractionsbetweenapolipoproteineandamyloidproteinsinneurodegenerativediseases
AT angelikichroni crossinteractionsbetweenapolipoproteineandamyloidproteinsinneurodegenerativediseases
AT jinghuiluo crossinteractionsbetweenapolipoproteineandamyloidproteinsinneurodegenerativediseases